Staar Surgical (STAA) Capital Expenditures (2010 - 2026)

Staar Surgical (STAA) has reported Capital Expenditures for 17 consecutive years, with $494000.0 the latest figure, recorded in Q3 2026.

• For the quarter ending Q3 2026, Capital Expenditures fell 72.43% year-over-year to $494000.0; the trailing twelve-month figure through Jul 2026 stood at $3.5 million (down 77.02% YoY), and the FY2026 full-year result was $5.8 million, down 75.12% from the prior year.
• Capital Expenditures improved to $494000.0 in Q3 2026 per STAA's latest filing, from $443000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $9.2 million in Q3 2023 and bottomed at $443000.0 in Q2 2026.
• Historically, Capital Expenditures has averaged $3.7 million across 5 years, with a median of $3.1 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Capital Expenditures surged 106.9% in 2024, then tumbled 85.83% in 2025.
• Over 5 years, Capital Expenditures stood at $4.0 million in 2022, then dropped by 23.28% to $3.1 million in 2023, then soared by 85.4% to $5.7 million in 2024, then sank by 84.58% to $883000.0 in 2025, then tumbled by 44.05% to $494000.0 in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $494000.0, $443000.0, and $1.7 million for Q3 2026, Q2 2026, and Q1 2026 respectively.